About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Levetiracetam in Central Pain in Multiple Sclerosis(MS)

Levetiracetam in Central Pain in Multiple Sclerosis(MS)

NCT00423527·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Odense University Hospital

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

ms diagnosis verified
age \> 18 years
central pain symptoms for more than 3 months
central pain diagnosis confirmed by neurological examination
adequate anticonceptive treatment for women with child bearing potential
informed consent
baseline pain of more than 4 on numeric rating scale

You may not be if

other cause of pain
previous allergic reaction towards levetiracetam
known adverse drug reaction on levetiracetam
pregnancy
severe disease
inability to follow study protocol
treatment with antidepressants, other anticonvulsants or opioids

The record

StatusCompleted

PhasePhase 4

Taking part30

StartedJan 2007

UpdatedDec 18, 2009

Conditions

Multiple Sclerosis

Where1

Department of Neurology, Odense University Hospital
Odense C, Denmark